TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Apparent Terminal Half-life (t1/2) of MK-4318
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Western Ontario Meniscus Assessment Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of participants who have 'recovered' from depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who have 'recovered' from anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants who have 'recovered' from insomnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Product Malfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Intraoperative Staple Line Bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Reported Device-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Quantitative neuroinflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Whole-body inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Global Assessment of Skin Overall Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Gastroesophageal varices bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Motor Development Quotient (QDM) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Health Literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection rates of OPMD and OSCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Level course of Willebrand Factor high molecular weight multimers in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frontal Plane Projection Angle (FPPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower Extremity Clinical Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioception Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of hemorrhoid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of clinical and laboratory adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Cellular immune response to Modi-1 on IFNγ ELISpot assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: BASMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Preservation of Diaphragm Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of Patient endangerment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dual-task gait cost
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dual-task cognitive cost
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of intubation for mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients successfully decolonised of CPE intestinal carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Confrontation Testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bells Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinetic Field Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of morphologically mature oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Total international units (IU) of recombinant FSH administrated
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of grade 1 embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Dose-limiting toxicity related to inoperability
Endpoint domain: Adverse events/effects
Primary endpoint: Dose-limiting toxicity related to perioperative complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: Severe delayed toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in glycated Hemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analog Score for pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tegner scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete recanalization rate of PVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: C.acnes Growth Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Freedom from PVC/VT recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cancer therapy-related cardiac dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in patient performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Caregiver satisfaction of patient performance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of 13C-short-chain fatty acids in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of attempts of each peripheral i.v. access placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time needed for each peripheral i.v. access placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Immunophenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lung microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical efficacy of IMM2510 in NSCLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical efficacy of IMM2510 in TNBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Completed OSA referral
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post-Traumatic Stress Disorder symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resilience scale-13 (RS-13)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Brief Resilience scale - German Version (BRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite of cardiovascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Non-motor symptomatology change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with pulmonary TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 3 years disease free survival
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive Impairment Identification Accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PostCovid Functional Status Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change in total lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective-response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-Minute Walk Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child BMI percentile at 6y
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child abdominal fat mass as measured by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child Liver fat content as measured by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thyroid hormones changes of biochemical parameters after rTMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Liver function related indexes changes of biochemical parameters after rTMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of status description of patients with different types of mental disorders treated with rTMS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Persistent Genital HPV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sustained QHPV vaccine specific antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants with clinically significant shifts in haematology/clinical chemistry/coagulation/urinalysis values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ECG measurements from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patients' Confidence in Managing their Health Condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Extent of shared decision making
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Successful extension of labor epidural catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Metastatic rate of No.253 lymph node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients with hematologic remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in observed hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Violence Risk Scale-Sexual Offense Version (VRS:SO)
Endpoint domain: Adverse events/effects
Primary endpoint: Aggression Questionnaire (AQ; Buss &amp) - Physical Aggression, Verbal Aggression, and Anger Subscales ONLY
Endpoint domain: Adverse events/effects
Primary endpoint: Arterial calcification score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in total score of Barratt Impulsiveness Questionnaire version 11 (BIS-11) after single dose
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in total score of Barratt Impulsiveness Questionnaire BIS-11 at steady state
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in total score of S-UPPS-P Impulsive Behavior Scale after single dose
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from baseline in total score of S-UPPS-P Impulsive Behavior Scale at steady state
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of stomach pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intensity of stomach cramps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of participants with early stage lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Radiographic Progression-free survival (rPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients developing contra-lateral neck cancer
Endpoint domain: Mortality/survival
Primary endpoint: Median percent change in monthly PGTCS frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Proportion of women with Pre-Exposure Prophylaxis uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PET Uptake of Tracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEGUE scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: JSE-S scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physician knowledge assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician technical skills assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responders and non-responders proportion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in number of blue balloons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of abortive hemangioma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of early extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of impaired cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in MRI sinus opacification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in olfactory bulb volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Poly-metastatic free survival (PMFS)
Endpoint domain: Mortality/survival
Primary endpoint: Feasibility of CHW nutrition intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean total sodium in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of the index hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Management Outcome of Chronic Portal Vein Thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in child anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modified Alertness Sedation Score (MOAA/S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Esophageal Mucosa Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Recruitment rate (%)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Drop-out rate (%)
Endpoint domain: Adverse events/effects
Primary endpoint: Alignment PPG measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LAMP2 myocardial tissue expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Aspirin Reaction Units (ARU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Thromboxane B2 (TxB2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of Dry Eye on Everyday Life questionnaire mean scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Work Productivity and Activity Impairment mean scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Frequency of DED-related hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change from Baseline Pain via Numeric Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Improvement in Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total morphine consumption in milligrams
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioceptive accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported physical activity from baseline to 3-6-months post-move-in
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported physical activity from baseline to 9-12-months post-move-in
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in accelerometer-measured physical activity from baseline to 3-6-months post-move-in
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in accelerometer-measured physical activity from baseline to 9-12-months post-move-in
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in prescribed evidence-based HFrEF medical therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of cardiometabolic diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Performance of detection algorithm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paired difference in percentage CNC words correct
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paired difference in dB SRT (AuSTIN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Resolution of normal and cancerous tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Cores Successfully Removed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Behavior and Feelings Survey (Internalizing Subscale) From Baseline to 3-month Follow-Up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Behavior and Feelings Survey (Internalizing Subscale) From Baseline to 12-month Follow-Up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in State Hope Scale Pathways Subscale From Immediately Pre-Intervention to Immediately Post-Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Beck Hopelessness Scale From Immediately Pre-Intervention to Immediately Post-Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: diagnosis performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of MK-7762
Endpoint domain: Adverse events/effects
Primary endpoint: Laboratory results after administration of MK-7762
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrocardiogram (ECG) parameters after administration of MK-7762
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vital signs after administration of MK-7762
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in blood concentrations of cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean difference in survey responses
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Positive and Negative Affect Schedule (PANAS-SF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-confidence regarding treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: diagnose accordance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with DLT (Dose limiting Toxicity)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects with adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects with serious adverse event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects with immune related adverse event (irAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative incidence of inhibitors to FVIII
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Immune Tolerance Induction (ITI) success cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Immune Tolerance Induction (ITI) partial success cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Keratinized Tissue Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival margin level in relation to the Cemento Enamel Junction CEJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: movement score during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first movement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First occurrence of COVID-19 at least 14 days after the second vaccination
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of severe solicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of AEs and Serious AEs (SAEs) after each vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Esophageal product time pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Nasal complications
Endpoint domain: Adverse events/effects